HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat-Dx Rise – a high-capacity version of the QIAstat-Dx ...
Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...
The clinical laboratory occupies a central role in modern healthcare by providing essential data that guide patient management and treatment decisions. At the heart of this process lies the total ...
The landscape of workplace safety and personal health screenings in the Greater Boston area involves a variety of technical procedures that can often seem complex to the uninitiated. In a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results